Literature DB >> 27102418

Cancer-associated myositis associated with oesophageal adenocarcinoma arising in Barrett's oesophagus without serum myogenic enzymes elevation: an example suggesting the importance of MRI.

Yosuke Sasaki1, Hiroshige Shimizu2, Tetsuo Nemoto3, Yoshihisa Urita1.   

Abstract

The strong association between myositis and malignancy has been well recognised. Cancer-associated myositis (CAM) is thought to be a cross-reaction to regenerating muscle tissue similar to tumour antigen. We report a case of CAM due to oesophageal adenocarcinoma arising in Barrett's oesophagus without elevation of myogenic enzymes, diagnosed by MRI and repeated endoscopy. Elderly onset, prominent symptoms, lack of interstitial pneumonia, poorer response to immunosuppressive therapies, and the combination of negative conventional myositis-related antibodies and positive anti-p155/140 antibody may help to distinguish CAM from idiopathic inflammatory myopathy. As the prognosis of patients with CAM depends on the malignancy, aggressive diagnosis of CAM and the causative malignancy is required. Our experience underscores the importance of avoiding the over-reliance on serum myogenic enzymes for excluding CAM and recognising MRI as a useful diagnostic tool of myositis. 2016 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Year:  2016        PMID: 27102418      PMCID: PMC4840713          DOI: 10.1136/bcr-2016-215047

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  17 in total

1.  Parathyroid hormone-related protein production by adenocarcinoma in Barrett's esophagus patient with dermatomyositis.

Authors:  S Tanabe; H Mitomi; M Sada; I Yamazaki; T Akaboshi; I Okayasu; T Kameya; K Saigenji
Journal:  Dig Dis Sci       Date:  2001-07       Impact factor: 3.199

2.  Malignancy in adult dermatomyositis.

Authors:  Y H Leow; C L Goh
Journal:  Int J Dermatol       Date:  1997-12       Impact factor: 2.736

3.  Predicting factors of malignancy in dermatomyositis and polymyositis: a case-control study.

Authors:  Y J Chen; C Y Wu; J L Shen
Journal:  Br J Dermatol       Date:  2001-04       Impact factor: 9.302

4.  Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study.

Authors:  C L Hill; Y Zhang; B Sigurgeirsson; E Pukkala; L Mellemkjaer; A Airio; S R Evans; D T Felson
Journal:  Lancet       Date:  2001-01-13       Impact factor: 79.321

Review 5.  Paraneoplastic syndromes in rheumatology.

Authors:  Bernhard Manger; Georg Schett
Journal:  Nat Rev Rheumatol       Date:  2014-08-19       Impact factor: 20.543

6.  Classical and amyopathic dermatomyositis seen at the National Skin Centre of Singapore: a 3-year retrospective review of their clinical characteristics and association with malignancy.

Authors:  P Ang; M W Sugeng; S H Chua
Journal:  Ann Acad Med Singap       Date:  2000-03       Impact factor: 2.473

7.  Cancer-associated myositis: clinical features and prognostic signs.

Authors:  Andrea Ponyi; Tamás Constantin; Miklós Garami; Csilla András; Béla Tállai; Andrea Váncsa; Lajos Gergely; Katalin Dankó
Journal:  Ann N Y Acad Sci       Date:  2005-06       Impact factor: 5.691

8.  Dermatomyositis and esophageal cancer.

Authors:  Imran Iftikhar; Dima Abdelmannan; Hamed A Daw
Journal:  South Med J       Date:  2006-07       Impact factor: 0.954

9.  The diagnostic utility of myositis autoantibody testing for predicting the risk of cancer-associated myositis.

Authors:  Hector Chinoy; Noreen Fertig; Chester V Oddis; William E R Ollier; Robert G Cooper
Journal:  Ann Rheum Dis       Date:  2007-03-28       Impact factor: 19.103

10.  Laboratory Test Abnormalities are Common in Polymyositis and Dermatomyositis and Differ Among Clinical and Demographic Groups.

Authors:  Rita Volochayev; Gyorgy Csako; Robert Wesley; Lisa G Rider; Frederick W Miller
Journal:  Open Rheumatol J       Date:  2012-06-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.